Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies

• Diana Gulei,
• Ciprian Tomuleasa,
• Ciprian Tomuleasa,
• Liren Qian,
• Cristina Bagacean,
• Cristina Bagacean,
• Carlo M. Croce,
• Gabriel Ghiaur

Affiliations

Diana Gulei

Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania

Ciprian Tomuleasa

Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania

Ciprian Tomuleasa

Department of Hematology, Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania

Liren Qian

Department of Hematology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China

Cristina Bagacean

INSERM UMR1227, B lymphocytes and autoimmunity, University of Brest, Brest, France

Cristina Bagacean

Service d’Hématologie, Centre Hospitalier Régional et Universitaire de Brest, Brest, France

Carlo M. Croce

Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, OH, United States

Gabriel Ghiaur

Department of Leukemia, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, United States